middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
pathogen
capabl
caus
sever
respiratori
diseas
human
although
dromedari
camel
consid
major
reservoir
host
merscov
infect
dynam
camel
fulli
understood
surveil
pakistan
nasal
n
serum
n
sampl
collect
camel
novemb
februari
sampl
collect
anim
market
freeroam
herd
abattoir
inhous
elisa
develop
detect
igg
merscov
total
camel
found
seroposit
merscov
preval
increas
age
highest
seropreval
record
camel
age
year
follow
age
year
b
year
higher
preval
observ
femal
compar
male
camel
nasal
swab
found
posit
rtqpcr
though
high
ct
valu
moreov
human
serum
sampl
also
collect
four
provinc
pakistan
among
sampl
popul
human
camel
herder
although
found
high
rate
merscov
antibodi
posit
dromedari
pakistan
neutral
antibodi
detect
human
without
contact
camel
middl
east
respiratori
syndrom
coronaviru
merscov
posit
sens
singlestandard
rna
viru
genu
betacoronaviru
zoonot
pathogen
capabl
caus
sever
respiratori
diseas
human
septemb
merscov
first
detect
human
may
merscov
infect
report
countri
laboratoryconfirm
case
human
least
relat
death
major
case
saudiarabia
ksa
high
preval
merscov
dromedari
camel
direct
contact
infect
camel
link
human
infect
gossner
et
al
haagman
et
al
alraddadi
et
al
moreov
larg
hospit
link
outbreak
also
report
case
import
countri
park
et
al
accumul
evid
suggest
camel
reservoir
merscov
although
camel
human
transmiss
document
human
infect
due
human
human
transmiss
especi
healthcar
set
park
et
al
geograph
comprehens
studi
ksa
merscov
antibodi
detect
approxim
sampl
human
popul
depict
sporad
infect
without
sever
diseas
et
al
significantli
higher
seropreval
observ
slaughterhous
worker
camel
shepherd
et
al
high
preval
merscov
antibodi
report
camel
differ
countri
arabian
peninsula
saudiarabia
unit
arab
emir
qatar
oman
africa
kenya
sudan
nigeria
burkina
faso
ethiopia
morocco
gossner
et
al
werneri
et
al
haagman
et
al
reusken
et
al
munyua
et
al
et
al
chu
et
al
presenc
merscov
neutral
antibodi
archiv
camel
sera
suggest
longterm
circul
viru
among
camel
popul
howev
recent
studi
australia
china
kazakhstan
suggest
evid
merscov
infect
dromedari
bactrian
camel
crameri
et
al
liu
et
al
miguel
et
al
smallscal
studi
punjab
pakistan
report
high
percentag
dromedari
neutral
antibodi
merscov
saqib
et
al
contrast
lack
report
human
merscov
infect
pakistan
view
uncertain
diseas
preval
limit
capac
routin
surveil
consider
larg
human
dromedari
popul
conduct
countrywid
crosssect
studi
merscov
infect
dromedari
human
interest
global
public
health
agenc
aim
studi
determin
countrywid
preval
merscov
camel
human
popul
pakistan
crosssect
studi
design
determin
preval
merscov
camel
human
popul
pakistan
camel
sampl
site
chosen
base
dromedari
popul
presenc
veterinari
clinic
fig
camel
nasal
swab
collect
collect
swab
place
tube
contain
rnalat
ambion
austin
usa
store
total
dromedari
sera
also
collect
use
blood
collect
system
bectondickinson
co
san
jose
usa
take
blood
sampl
clinic
paramet
includ
rectal
temperatur
bodi
condit
symptom
diseas
also
record
human
sampl
site
randomli
chosen
repres
rural
periurban
urban
area
pakistan
sampl
site
rural
area
purpos
chosen
due
abund
camel
popul
area
inform
relat
demograph
exposur
anim
anim
product
also
record
human
serum
sampl
obtain
hospit
primari
health
care
centr
blood
bank
peopl
older
year
age
codonoptim
rbdregion
gene
merscov
access
number
correspond
aa
spike
protein
synthes
sangon
biotech
sangon
biotech
shanghai
china
synthes
sequenc
clone
xho
hind
iii
site
mammalian
express
vector
pcaggsstag
protein
express
cell
briefli
cell
seed
larg
cultur
dish
u
cm
grown
confluenc
cell
transfect
pcaggsmerscovrbd
plasmid
use
lipofectamin
invitrogen
carlsbad
usa
follow
manufactur
instruct
six
hour
posttransfect
cultur
medium
replac
freestyletm
express
medium
gibco
grand
island
usa
cell
incub
h
cell
cultur
supernat
collect
merscovrbd
fusion
protein
purifi
use
sprotein
agaros
novagen
madison
usa
follow
manufactur
protocol
concentr
mgml
amicon
centrifug
filter
k
millipor
bedford
usa
centrifug
g
purifi
protein
analys
sdspage
western
blot
fig
serolog
twostep
approach
recommend
detect
antibodi
merscov
use
inhous
antimerscov
igg
relisa
kit
develop
briefli
maxisorp
nuncimmuno
well
elisa
plate
coat
ngwell
overnight
recombin
rbd
protein
merscov
camel
sera
appli
dilut
h
anticamel
igghrp
conjug
monoclon
antibodi
kyab
biotech
coltd
wuhan
china
use
dilut
od
valu
calcul
basi
viru
neutral
test
cutoff
valu
set
camel
sera
confirm
assay
sensit
total
mer
igg
posit
sampl
commerci
elisa
euroimmun
lubeck
germani
neutral
assay
previou
studi
util
saqib
et
al
calcul
specif
mer
igg
neg
sampl
elisa
euroimmun
lubeck
germani
neutral
assay
test
similar
commerci
avail
elisa
euroimmun
lubeck
germani
inhous
elisa
found
sensit
specif
human
serolog
sera
sampl
appli
dilut
h
antihuman
igghpr
conjug
monoclon
antibodi
kyab
biotech
coltd
wuhan
china
use
dilut
sampl
optic
densiti
ratio
c
high
three
time
ratio
mean
valu
test
human
serum
sampl
without
known
exposur
camel
test
commerci
avail
elisa
kit
euroimmun
lubeck
germani
elisa
posit
sampl
subject
microneutr
assay
describ
previous
perera
et
al
briefli
sera
heatinactiv
min
dilut
sera
dilut
mix
equal
volum
tcid
merscov
h
incub
virusserum
mixtur
ad
quadrupl
vero
cell
monolay
microtit
plate
h
adsorpt
media
remov
cell
wash
dmem
addit
cultur
medium
dmem
fb
ad
well
plate
incub
three
day
co
humidifi
incub
cytopath
effect
cpe
read
three
day
post
infect
posit
neg
control
sera
includ
valid
assay
antibodi
titr
regard
posit
test
algorithm
merscov
implement
camel
nasal
swab
viral
rna
extract
use
viral
rna
extract
kit
roch
mannheim
germani
accord
manufactur
instruct
sampl
test
presenc
merscov
rna
use
rtqpcr
assay
describ
previous
lu
et
al
sampl
posit
assay
confirm
rtqpcr
assay
sampl
posit
assay
subject
nest
heminest
pcr
n
gene
describ
elsewher
corman
et
al
assiri
et
al
sanger
sequenc
perform
abi
file
analys
geneiou
sequenc
submit
genbank
access
number
elisa
posit
sampl
analys
statist
associ
age
sex
locat
use
v
test
p
valu
consid
signific
analys
univari
analysi
perform
odd
ratio
along
confid
interv
ci
calcul
determin
associ
preval
differ
variabl
analysi
perform
r
use
packag
epicalc
total
sampl
found
posit
two
independ
rtqpcr
assay
eg
rtqpcr
though
high
ct
valu
addit
one
sampl
abl
amplifi
partial
nucleocapsid
spike
gene
segment
genbank
access
no
size
bp
bp
respect
sequenc
obtain
pakistani
camel
ident
sever
alreadi
publish
sequenc
obtain
camel
well
human
arabian
peninsula
unfortun
like
due
rna
degrad
unabl
recov
addit
sequenc
confid
fidel
find
first
viral
rna
extract
rtqpcr
experi
perform
laboratori
previou
merscov
work
ever
done
second
heminest
pcr
n
gene
repeat
two
independ
laboratori
two
differ
person
yield
ident
result
result
indic
activ
circul
closelyrel
ident
strain
circul
pakistan
compar
arabian
peninsula
serolog
camel
serum
sampl
collect
femal
male
camel
major
sera
punjab
provinc
seminomad
distribut
sera
age
sex
type
herd
sampl
locat
present
tabl
camel
sera
test
elisa
sera
found
posit
elisa
fig
verifi
elisa
result
elisa
posit
elisa
neg
sampl
randomli
chosen
test
merscov
neutral
antibodi
microneutr
assay
describ
elsewher
perera
et
al
neutral
assay
result
found
agreement
elisa
result
confirm
sensit
specif
inhous
elisa
total
human
sera
sampl
collect
four
provinc
pakistan
sampl
femal
male
sampl
popul
involv
livestock
rear
among
sampl
popul
human
camel
herder
total
human
sera
sampl
od
valu
c
high
three
time
ratio
mean
valu
test
human
serum
sampl
without
known
exposur
camel
test
commerci
avail
elisa
kit
euroimmun
lubeck
germani
thirtysix
sampl
found
posit
commerci
elisa
od
valu
c
fig
reactiv
sampl
punjab
provinc
pakistan
note
elisa
posit
camel
herder
confirm
presenc
antibodi
sampl
sera
test
merscov
neutral
antibodi
microneutr
assay
describ
elsewher
perera
et
al
none
posit
surveil
emerg
zoonot
virus
key
element
one
health
program
present
studi
seropreval
merscov
camel
human
popul
four
provinc
pakistan
estim
camel
four
provinc
pakistan
show
evid
past
merscov
infect
test
posit
merscov
elisa
overal
seropreval
data
agreement
studi
camel
rear
countri
falzarano
et
al
munyua
et
al
previou
studi
pakistan
also
describ
high
seropreval
merscov
camel
saqib
et
al
howev
studi
cover
limit
area
punjab
provinc
pakistan
studi
cover
camel
rear
area
punjab
provinc
also
cover
three
provinc
pakistan
observ
high
seropreval
merscov
antibodi
bahawalnagar
district
pakistan
border
rajasthan
state
india
fig
rais
possibl
spectr
similar
level
preval
although
studi
yet
undertaken
rajasthan
india
presenc
iggposit
anim
kpk
balochistan
provinc
pakistan
expand
distribut
merscov
westward
balochistan
share
border
afghanistan
iran
countri
harbour
larg
popul
camel
studi
carri
countri
around
border
area
determin
ecolog
merscov
region
significantli
higher
seropreval
observ
old
age
camel
studi
similar
agedepend
differ
previous
report
could
due
regular
reexposur
merscov
initi
infect
countrywid
high
preval
merscov
dromedari
suggest
risk
human
exposur
similar
one
report
arabian
peninsula
sampl
test
sampl
posit
commerci
elisa
howev
none
test
posit
neutral
antibodi
merscov
previou
studi
ksa
report
time
increas
risk
seroposit
merscov
person
occup
exposur
camel
et
al
among
test
popul
pakistan
person
camel
herder
camel
herder
close
interact
camel
includ
direct
handl
ie
herd
milk
slaughter
consumpt
unpasteur
milk
local
practic
camel
herder
provid
plenti
opportun
contact
camel
product
despit
humancamel
interact
neutral
antibodi
merscov
found
human
individu
may
impli
cameltohuman
transmiss
studi
popul
period
although
camelhuman
transmiss
merscov
infrequ
arabian
peninsula
africa
howev
absenc
neutral
antibodi
camel
herd
commun
unanticip
find
corrobor
previou
studi
kenya
report
elisa
posit
instanc
neutral
neg
human
sera
liljand
et
al
munyua
et
al
therefor
possibl
merscov
strain
circul
pakistan
kenya
antigen
differ
strain
use
neutral
assay
liljand
et
al
munyua
et
al
moreov
short
lifespan
antimerscov
antibodi
especi
human
mild
diseas
may
explain
absenc
detect
neutral
antibodi
alshukairi
et
al
result
suggest
like
reduc
transmiss
merscov
camel
human
level
exposur
person
ksa
though
mechan
unclear
albeit
studi
larg
human
popul
pakistan
past
exposur
merscov
infect
howev
owe
potenti
wane
immun
subclin
merscov
infect
human
possibl
studi
provid
finit
opportun
make
conclus
statement
exposur
statu
merscov
human
pakistan
prospect
studi
need
conduct
undertak
factor
respons
rariti
seroposit
merscov
camel
herder
pakistan
high
seropreval
merscov
among
young
camel
indic
recent
activ
circul
merscov
camel
popul
pakistan
activ
circul
merscov
pakistan
confirm
detect
merscov
nasal
swab
sampl
rtqpcr
assay
studi
continu
circul
merscov
camel
popul
pakistan
pose
possibl
risk
human
transmiss
camel
herder
peopl
frequent
contact
camel
product
one
hand
activ
viru
circul
high
seropreval
merscov
camel
popul
observ
wherea
absenc
human
case
pakistan
pose
german
question
regard
viral
epidemiolog
differ
geograph
ecolog
zone
best
knowledg
first
countrywid
studi
merscov
seropreval
camel
human
popul
pakistan
longitudin
studi
among
camel
herd
commun
well
studi
detect
character
merscov
strain
camel
pakistan
warrant
